SEQ-9

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Showing the 100 most relevant patent families.

DUAL TARGETING FOR CELL-SPECIFIC DELIVERY TO THE CENTRAL NERVOUS SYSTEM
Applicant: STANFORD RES INST INTPriority: 2021
CN
EP
US
WO
6 publications
Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
Applicant: LERCHL JENSPriority: 2001
EP
US
WO
5 publications
Selective substrates for matrix metalloproteinases
Applicant: SMITH JEFFREY WPriority: 2002
US
5 publications
HIV fusion inhibitor peptides with improved biological properties
Applicant: TRIMERIS INCPriority: 2007
US
5 publications
SEPARATION MATRIX
Applicant: CYTIVA BIOPROCESS R & D ABPriority: 2020
CN
EP
US
WO
4 publications
METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES
Applicant: PEPGEN INCPriority: 2021
CN
EP
US
WO
4 publications
NKP46 ANTIBODY AND USE THEREOF
Applicant: HEFEI TG IMMUNOPHARMA CO LTDPriority: 2022
CN
EP
US
WO
4 publications
HUMANIZED ANTI-HUMAN ALPHA 9-INTEGRIN ANTIBODY
Applicant: JURIDICAL FDN THE CHEMO SERO THERAPEUTIC RES INSTPriority: 2008
CN
US
4 publications
PCSK9 peptide combination vaccine and method of use
Applicant: BRUNNER SYLVIAPriority: 2011
CN
US
4 publications
Use of aspartic proteases in cosmetics and therapeutics
Applicant: OREALPriority: 2002
US
4 publications